The Jaffe Food Allergy Institute in conjunction with Icahn School of Medicine is taking part in a first of its kind research study that may help prevent allergies and asthma in high-risk children. High-risk children include those with allergic reactions, eczema and a family history of asthma or allergies. This world-wide study involves exposing babies and toddlers to tiny doses of common allergens as an oral vaccine to stimulate immune responses, with the goal of preventing allergies and asthma. The study is funded by the National Institutes of Health and conducted by the Immune Tolerance Network.